siRNA, Anti-ERVH48-1, 2'-F/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT52393WQ-2F)
The product SIRGT52393WQ-2F is a type of small interfering RNA (siRNA) that targets ERVH48-1 gene and regulates the expression of gene. The siRNA interferes with the expression of ERVH48-1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-deoxy-2ʹ-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_001308491.1 |
| Alternative Names | C21orf105; NDUFV3-AS1 |
| Related Diseases | Gastric Cancer |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT53393WQ-2MOE | ERVH48-1 | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT54393WQ-LNA | ERVH48-1 | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT51393WQ-RB | ERVH48-1 | Human | Ribo-modified | ||
| SIRGT52393WQ-BB | ERVH48-1 | Human | Backbone-modified |
